The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

Gut Zoomer provides insights crucial in identifying the root causes of chronic disease and other conditions that impact longevity SANTA CLARA, CA / ACCESS Newswire / July 8, 2025 / Vibrant Wellness, a ...

Fecal immunochemical testing (FIT) has emerged as a pivotal tool in the non‐invasive screening and diagnostic pathway for CRC, offering a reliable method to detect occult blood in stool samples.

Colorectal cancer is the second most common cause of cancer-related death in women and the third most common in men. Since ...

Research published in the scientific journal The Lancet found that fecal immunochemical testing (FIT) was comparable to colonoscopy when it came to reducing deaths from colon and ...

The recent surge in early-onset colorectal cancer, particularly in adults under 50, has sparked urgent concerns about the adequacy of current screening gui | Cancer ...

Daily Hemoccult testing of stools in 95 low-birth-weight neonates who were being fed revealed no relationship between the development of NEC and preceding occult blood in the stools.

Hemorrhoids and colon cancer can both cause symptoms of rectal bleeding, but diagnosis and treatment are different. It's important to get either condition diagnosed.

Routine stool screening for occult blood is expensive. What does the evidence say about its effectiveness as a diagnostic or screening tool?

Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.

An estimated 10-15 percent of American adults suffer from irritable bowel syndrome (IBS). Proper diagnosis from a medical professional is important for getting effective treatment and relief.

NEW YORK – QuidelOrtho announced Monday an integration deal making fecal biomarker testing from Bühlmann Laboratories available on QuidelOrtho's Vitros system. The Bühlmann fecal tests detect ...